ShockWave Medical Research and Development Expenses 2018-2023 | SWAV
ShockWave Medical annual/quarterly research and development expenses history and growth rate from 2018 to 2023. Research and development expenses can be defined as an expense arising from studies and product development processes.
- ShockWave Medical research and development expenses for the quarter ending December 31, 2023 were $0.042B, a 78.4% increase year-over-year.
- ShockWave Medical research and development expenses for the twelve months ending December 31, 2023 were $0.146B, a 78.32% increase year-over-year.
- ShockWave Medical annual research and development expenses for 2023 were $0.146B, a 78.32% increase from 2022.
- ShockWave Medical annual research and development expenses for 2022 were $0.082B, a 61.6% increase from 2021.
- ShockWave Medical annual research and development expenses for 2021 were $0.051B, a 36.88% increase from 2020.
| ShockWave Medical Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023 | $146 |
| 2022 | $82 |
| 2021 | $51 |
| 2020 | $37 |
| 2019 | $33 |
| 2018 | $23 |
| 2017 | $18 |
| ShockWave Medical Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2023-12-31 | $42 |
| 2023-09-30 | $40 |
| 2023-06-30 | $37 |
| 2023-03-31 | $27 |
| 2022-12-31 | $24 |
| 2022-09-30 | $20 |
| 2022-06-30 | $21 |
| 2022-03-31 | $17 |
| 2021-12-31 | $15 |
| 2021-09-30 | $14 |
| 2021-06-30 | $12 |
| 2021-03-31 | $10 |
| 2020-12-31 | $9 |
| 2020-09-30 | $8 |
| 2020-06-30 | $8 |
| 2020-03-31 | $12 |
| 2019-12-31 | $10 |
| 2019-09-30 | $8 |
| 2019-06-30 | $7 |
| 2019-03-31 | $7 |
| 2018-12-31 | $6 |
| 2018-09-30 | $6 |
| 2018-06-30 | $6 |
| 2018-03-31 | $6 |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.422B | $0.730B |
| ShockWave Medical, Inc. is a medical device company. It is focused on developing and commercializing products for medical device treatment of atherosclerotic cardiovascular disease. ShockWave Medical, Inc. is based in Santa Clara, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.656B | 27.71 |
| Intuitive Surgical (ISRG) | United States | $141.664B | 85.34 |
| Edwards Lifesciences (EW) | United States | $54.330B | 35.36 |
| DexCom (DXCM) | United States | $51.584B | 78.14 |
| IDEXX Laboratories (IDXX) | United States | $45.302B | 53.10 |
| Alcon (ALC) | Switzerland | $44.364B | 31.79 |
| IQVIA Holdings (IQV) | United States | $42.578B | 24.70 |
| STERIS (STE) | Ireland | $23.267B | 27.19 |
| Waters (WAT) | United States | $21.461B | 31.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.656B | 0.00 |
| Hologic (HOLX) | United States | $17.471B | 19.55 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.151B | 15.35 |
| Sysmex ADR (SSMXY) | Japan | $11.022B | 34.56 |
| Teleflex (TFX) | United States | $10.353B | 16.11 |
| Globus Medical (GMED) | United States | $8.736B | 25.61 |
| Penumbra (PEN) | United States | $7.935B | 90.18 |
| Masimo (MASI) | United States | $6.166B | 35.52 |
| Glaukos (GKOS) | United States | $5.610B | 0.00 |
| TransMedics (TMDX) | United States | $4.484B | 425.44 |
| Integer Holdings (ITGR) | United States | $3.944B | 23.83 |
| PROCEPT BioRobotics (PRCT) | United States | $3.558B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.422B | 20.32 |
| Tandem Diabetes Care (TNDM) | United States | $3.060B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.923B | 20.05 |
| Inari Medical (NARI) | United States | $2.732B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.428B | 20.53 |
| RxSight (RXST) | United States | $2.378B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.086B | 9.10 |
| Veracyte (VCYT) | United States | $1.800B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.604B | 0.00 |
| Artivion (AORT) | United States | $0.990B | 94.92 |
| OPKO Health (OPK) | United States | $0.941B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.919B | 17.88 |
| Silk Road Medical (SILK) | United States | $0.854B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.748B | 0.00 |
| Paragon 28 (FNA) | United States | $0.672B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.640B | 21.72 |
| SiBone (SIBN) | United States | $0.623B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.584B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| IRadimed (IRMD) | United States | $0.534B | 29.89 |
| Pulse Biosciences (PLSE) | United States | $0.401B | 0.00 |
| Nevro (NVRO) | United States | $0.388B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.325B | 11.13 |
| Sight Sciences (SGHT) | United States | $0.276B | 0.00 |
| AxoGen (AXGN) | United States | $0.260B | 0.00 |
| NeuroPace (NPCE) | United States | $0.260B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.255B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.250B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.202B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.200B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.175B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.167B | 8.49 |
| Yubo Biotech (YBGJ) | China | $0.109B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.107B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.101B | 21.17 |
| Neuronetics (STIM) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.060B | 0.00 |
| Envoy Medical (COCH) | United States | $0.059B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| DarioHealth (DRIO) | United States | $0.055B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.051B | 0.00 |
| LENSAR (LNSR) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.034B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |